Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Baoxin Pill (MUSKARDIA) in Acute Myocardial Infarction
NCT07153744Phase 4Not yet recruiting
- Start
- Sep 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Shexiang Baoxin Pill in acute myocardial infarction (AMI). Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Shexiang Baoxin Pill
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT07153744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07153744.